Abstract
Toward Minimally Invasive Extracorporeal Circulation in Oncologic Cardiac Surgery.
Highlights
Several series indicated that surgical stress suppresses the immune system and that the use of cardiopulmonary bypass (CPB), cardiac arrest, and ischemia contributes to this
We present a letter to the editor on the potential role of minimally invasive extracorporeal circulation technologies (MiECT) in oncologic cardiac surgery
MiECT include a number of interventions aimed to reduce the clinical impact of CPB and to contain postoperative morbidity and mortality
Summary
Several series indicated that surgical stress suppresses the immune system and that the use of CPB, cardiac arrest, and ischemia contributes to this. It seems that the survival of cancer patients who undergo cardiac surgery is more closely related to the progression of the tumor than the surgical procedure[2]. Adverse effects of CPB on cancer prognosis are expected, but have not been confirmed.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
